Literature DB >> 12631132

Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.

John R Asplin1, Kimberly A Bauer, Jennifer Kinder, Georg Müller, Brian J Coe, Joan H Parks, Fredric L Coe.   

Abstract

BACKGROUND: Bone mineral density (BMD) is reduced among patients with idiopathic hypercalciuria (IH) and nephrolithiasis. To disentangle effects of diet, stone formation, and physiology upon BMD, we studied vertebral and femoral neck BMD among relatives of hypercalciuric stone formers, and contrasted those with to those without stones.
METHODS: Among 59 subjects from 11 families, vertebral and femoral neck BMD, diet calcium intake, urine excretions of calcium, sodium, ammonium, titratable acid, sulfate, urea nitrogen, and serum levels of calcitriol and markers of bone turnover were studied.
RESULTS: Stone formers (SF) consumed less calcium than non-stone formers (NSF). Spine and femoral neck BMD z-scores varied inversely with urine calcium loss and urine ammonium excretion among SF but not NSF. No correlations of BMD z-score were found for bone markers, calcitriol, or any of the other measurements.
CONCLUSION: SF consumed less calcium, presumably to prevent more stones, and displayed a bone mineral responsiveness to calcium loss and ammonium excretion not present among NSF, who ate more calcium. Lowered calcium consumption in IH, perhaps in response to stone formation, alters bone responses in a direction that can predispose to mineral loss and eventual fracture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631132     DOI: 10.1046/j.1523-1755.2003.00763.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  38 in total

Review 1.  Bone disease and idiopathic hypercalciuria.

Authors:  Joseph E Zerwekh
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

Review 2.  Bone disease and hypercalciuria in children.

Authors:  Joseph E Zerwekh
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

3.  Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density.

Authors:  Gudmar Thorleifsson; Hilma Holm; Vidar Edvardsson; G Bragi Walters; Unnur Styrkarsdottir; Daniel F Gudbjartsson; Patrick Sulem; Bjarni V Halldorsson; Femmie de Vegt; Frank C H d'Ancona; Martin den Heijer; Leifur Franzson; Claus Christiansen; Peter Alexandersen; Thorunn Rafnar; Kristleifur Kristjansson; Gunnar Sigurdsson; Lambertus A Kiemeney; Magnus Bodvarsson; Olafur S Indridason; Runolfur Palsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

Review 4.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

5.  Stones: Bone health in patients with kidney stones.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin
Journal:  Nat Rev Urol       Date:  2014-12-09       Impact factor: 14.432

6.  Refining Diagnostic Approaches in Nephrolithiasis: Incomplete Distal Renal Tubular Acidosis.

Authors:  David S Goldfarb
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 8.237

7.  Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative.

Authors:  Laura D Carbone; Kathleen M Hovey; Christopher A Andrews; Fridtjof Thomas; Mathew D Sorensen; Carolyn J Crandall; Nelson B Watts; Monique Bethel; Karen C Johnson
Journal:  J Bone Miner Res       Date:  2015-07-14       Impact factor: 6.741

8.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

Review 9.  Insights Into Nephrolithiasis From the Nurses' Health Studies.

Authors:  Megan L Prochaska; Eric N Taylor; Gary C Curhan
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

Review 10.  Medical treatment of pediatric urolithiasis.

Authors:  Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-02-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.